Investor Relations

Investor Relations

BioSig Technologies, Inc Corporate Summary

November 2023

View Corporate Summary

Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023

Latest Annual Report

View Annual Report

Stock Information


Nasdaq: BSGM




52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Investor Relations

T: (203) 409-5444 x 133

Transfer Agent

Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088